Skip to main content
S&P 5007,656.98+0.86%DOW52,573.29+0.98%NASDAQ26,333.03+0.96%BTC$77,267.00+0.58%ETH$2,510.86+2.27%GOLD$4,390.00-0.39%OIL$99.99-2.43%
Smart Investors Daily
BioStem Technologies, Inc. logo

OTC · BSEM

BioStem Technologies, Inc.

Healthcare · Biotechnology

$4.31

Up+$0.14 (+3.23%)

Updated Sep 12, 2026, 11:07 PM

SID Score

4.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
70.33M
P/E ratio
3.5
Dividend yield
0.00%
52-week range
$2.25 – $4.66
Volume
143.08K
Avg. volume
68.56K

Price performance

BSEM price history

1M range · 0 trading sessions · Daily adjusted prices

BSEM does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest BSEM news

The latest Smart Investors Daily articles mentioning BSEM.

Stock researchCompany · Overview

BSEM research

Overview

Company profile and research snapshot.

Company profile

BIOSTEM TECHNOLOGIES NEW

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
BSEM recent ratings
DateFirmRatingTarget
Nov 7, 2022Zacks Investment ResearchBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 4, 2026

BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier

Additions extend BioStem's hospital channel to its BioRetain® wound care linePOMPANO BEACH, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that VENDAJE® and VENDAJE AC® have been added to the Company's existing contracts with Vizient, Inc. and Premier, Inc., two of the nati

Yahoo · Sep 3, 2026

BioStem Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

POMPANO BEACH, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York, NY and is scheduled to attend the conference on Monday, September 14. The Company’s fireside chat

Benzinga · Aug 13, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 48.4% to $0.16 during Thursday's regular session. The market value of their outstanding shares is at $7.2 million. BeyondSpring (NASDAQ:BYSI) shares moved

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By